[go: up one dir, main page]

DK1294372T3 - Törpulverformulering der omdanner racecadotril - Google Patents

Törpulverformulering der omdanner racecadotril

Info

Publication number
DK1294372T3
DK1294372T3 DK01969310T DK01969310T DK1294372T3 DK 1294372 T3 DK1294372 T3 DK 1294372T3 DK 01969310 T DK01969310 T DK 01969310T DK 01969310 T DK01969310 T DK 01969310T DK 1294372 T3 DK1294372 T3 DK 1294372T3
Authority
DK
Denmark
Prior art keywords
dry powder
racecadotril
transforms
powder formulation
formulation
Prior art date
Application number
DK01969310T
Other languages
English (en)
Inventor
Jeanne-Marie Lecomte
Jean-Charles Schwartz
Original Assignee
Bioprojet Soc Civ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioprojet Soc Civ filed Critical Bioprojet Soc Civ
Application granted granted Critical
Publication of DK1294372T3 publication Critical patent/DK1294372T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01969310T 2000-06-23 2001-06-22 Törpulverformulering der omdanner racecadotril DK1294372T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00401799 2000-06-23
PCT/EP2001/007086 WO2001097801A2 (en) 2000-06-23 2001-06-22 Dry powder formulation comprising racecadotril

Publications (1)

Publication Number Publication Date
DK1294372T3 true DK1294372T3 (da) 2005-09-19

Family

ID=8173739

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01969310T DK1294372T3 (da) 2000-06-23 2001-06-22 Törpulverformulering der omdanner racecadotril

Country Status (13)

Country Link
US (1) US6919093B2 (da)
EP (1) EP1294372B1 (da)
CN (2) CN1635884A (da)
AT (1) ATE301999T1 (da)
AU (1) AU2001289606A1 (da)
BG (1) BG66212B1 (da)
CA (1) CA2415957C (da)
CZ (1) CZ299591B6 (da)
DE (1) DE60112756T2 (da)
DK (1) DK1294372T3 (da)
ES (1) ES2247163T3 (da)
SK (1) SK287819B6 (da)
WO (1) WO2001097801A2 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2900823B1 (fr) * 2006-05-15 2009-02-13 Bioprojet Soc Civ Ile Nouvelle forme d'administration du racecadotril.
CN101103960B (zh) * 2006-07-14 2010-12-08 海南盛科生命科学研究院 一种含有消旋卡多曲的干混悬剂及其制备方法
EP2462922A1 (en) 2010-12-10 2012-06-13 Bioprojet New form of administration of enkephalinase inhibitor
CN102166197B (zh) * 2011-04-25 2012-09-05 四川百利药业有限责任公司 消旋卡多曲颗粒及其生产工艺
AU2012324534B2 (en) * 2011-10-18 2015-11-05 Purdue Pharma L.P. Acrylic polymer formulations
US10039712B2 (en) 2012-06-28 2018-08-07 Johnson & Johnson Consumer Inc. Racecadotril lipid compositions
NZ702930A (en) * 2012-06-28 2017-05-26 Mcneil Ppc Inc Racecadotril liquid compositions
US9114171B2 (en) * 2012-06-28 2015-08-25 Mcneil-Ppc, Inc. Racecadotril liquid compositions
US9801819B2 (en) 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
EP2749270B1 (en) * 2012-12-26 2018-01-17 ILKO Ilaç Sanayi ve Ticaret A.S. Racecadotril and pharmaceutical compositions thereof
EP2918268A1 (en) 2014-03-10 2015-09-16 Galenicum Health S.L. Pharmaceutical compositions comprising an active agent
EP2949318A1 (en) 2014-05-26 2015-12-02 Galenicum Health S.L. Pharmaceutical compositions comprising racecadotril
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril
EP3558272A1 (en) 2016-12-23 2019-10-30 Hermes Arzneimittel GmbH Oral pharmaceutical composition with improved taste-masking properties
WO2018163195A1 (en) 2017-03-06 2018-09-13 Athena Drug Delivery Solutions Pvt Ltd. A pharmaceutical composition comprising racecadotril and process for preparing the same
CN109589310A (zh) * 2017-10-01 2019-04-09 北京万全德众医药生物技术有限公司 消旋卡多曲干混悬剂及其制备方法
GB2586201B (en) * 2019-05-14 2023-05-24 Orbit Pharmaceuticals A stable powder formulation of racecadotril
EP4056171A1 (en) 2021-03-12 2022-09-14 Athena Pharmaceutiques SAS Taste masked racecadotril tablet composition and process for preparation thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
ZA919510B (en) * 1990-12-05 1992-10-28 Smithkline Beecham Corp Pharmaceutical compositions
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US20020028248A1 (en) * 1996-03-14 2002-03-07 Takayuki Tsukada Rapid-release microdispersible ecadotril preparation
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
US6270804B1 (en) * 1998-04-03 2001-08-07 Biovail Technologies Ltd. Sachet formulations
GB0015490D0 (en) * 2000-06-23 2000-08-16 Smithkline Beecham Lab Novel formulations

Also Published As

Publication number Publication date
CZ299591B6 (cs) 2008-09-10
SK287819B6 (sk) 2011-11-04
ATE301999T1 (de) 2005-09-15
EP1294372B1 (en) 2005-08-17
WO2001097801A3 (en) 2002-09-12
CN1635884A (zh) 2005-07-06
US20030166718A1 (en) 2003-09-04
DE60112756D1 (de) 2005-09-22
AU2001289606A1 (en) 2002-01-02
CZ2003185A3 (cs) 2003-05-14
SK762003A3 (en) 2003-07-01
US6919093B2 (en) 2005-07-19
CN102151247A (zh) 2011-08-17
DE60112756T2 (de) 2006-06-08
WO2001097801A2 (en) 2001-12-27
ES2247163T3 (es) 2006-03-01
CA2415957A1 (en) 2001-12-27
BG66212B1 (bg) 2012-05-31
BG107481A (bg) 2003-09-30
EP1294372A2 (en) 2003-03-26
CA2415957C (en) 2010-08-10

Similar Documents

Publication Publication Date Title
DK1294372T3 (da) Törpulverformulering der omdanner racecadotril
DE69907977D1 (de) Pyrrolobenzodiazepine
NO20024610D0 (no) Synergistiske metoder og blandinger for behandling av kreft
NO20024099L (no) Lavdose entecavir-formulering og anvendelse
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
DK1397174T3 (da) Pulverformulerings-desintegrationssystem og tørpulverinhalatorer
ATE514418T1 (de) Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan
ID30034A (id) Aralkil amina baru dari spirofuropiridin yang berguna dalam terapi
NO20031407L (no) Glukopyranosyloksybenzylbenzen-derivater og medisinske sammensetninger inneholdende det samme
FI971412L (fi) Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasien estäjinä
HUP0400202A3 (en) Imidazolidindion derivatives having metalloproteinase inhibitor effect, their use and pharmaceutical compositions containing them
PL366855A1 (en) Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
CY1110061T1 (el) Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης
EE05056B1 (et) IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette n„htud ateroskleroosi ravimiseks ja/v?i ennetamiseks
BR0210101A (pt) Combinações antineoplásticas
ATE275143T1 (de) Verbindungen
BR0308762A (pt) Formulação farmacêutica compreendendo melatonina
SI1197485T1 (en) Cyclobuten-dione derivatives for use in the treatment of artherosclerosis
EE200300213A (et) SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
PT1303520E (pt) Compostos terapêuticos e métodos
PT1263421E (pt) Avasimibe, o inibidor duplo da sintese de ester de colesterilo e de ester ceroso, para o tratamento de disturbios da glandula sebacea
DK1049468T3 (da) Anvendelse af hydroxypyridonholdige pudderpræparater til behandling af skinnebens- og tryksår
AR028122A1 (es) Nuevos compuestos aminotiolésteres, composiciones farmacéuticas y cosméticas que los contienen y utilizaciones
TR200002939T2 (tr) Paroksetin maleat